000130102 001__ 130102
000130102 005__ 20240122171020.0
000130102 0247_ $$2doi$$a10.1186/s41606-019-0040-8
000130102 0248_ $$2sideral$$a136489
000130102 037__ $$aART-2020-136489
000130102 041__ $$aeng
000130102 100__ $$aO’Connor Reina, Carlos
000130102 245__ $$aNew mHealth application software based on myofunctional therapy applied to sleep-disordered breathing in non-compliant subjects
000130102 260__ $$c2020
000130102 5060_ $$aAccess copy available to the general public$$fUnrestricted
000130102 5203_ $$aAbstract
Background
Myofunctional therapy (MT) is a therapeutic option with demonstrated efficacy for treating sleep-disordered breathing. We assessed the clinical application of a newly developed m-Health App, which aimed to allow patients with OSAHS (obstructive sleep apnea/hypopnea syndrome) to perform oropharyngeal exercises only by interacting with their smartphone without no other devices.
Methods
We offered to treat the OSAHS of 20 patients with the App for 90 sessions. Inclusion criteria were adult patients diagnosed with OSAHS who rejected, or could not tolerate or afford treatment for their OSAHS with other modalities. The App was used by 15 patients, while 5 were noncompliant and then were used as a control group. Polygraphy was performed at the beginning of the study, and after 90 sessions in the App group or after 3 months in the control group. Data for adherence to treatment, sex, body mass index (BMI), age, O2MIN (oxygen minimal saturation) and apnea–hypopnea index (AHI) were collected for both groups.
Results
15 (75%) patients showed adherence to the treatment as measured as performing the exercises daily 5 days a week. In patients who performed the exercises, AHI decreased from 25.78 ± 12.6 to 14.1 ± 7,7 (p = 0.002), Epworth changed from 18,2 ± 1,98 to 14,2 ± 7,7(p = 0,002) and (O2MIN) changed from 84,87 ± 7.02 to 89,27 ± 3,77 (p = 0.0189). In the control group, there was no significant change.
Conclusions
To our knowledge, this is the first study reported where a mHealth App based on MT could be by itself a therapeutic option in selected patients with OSAHS.
000130102 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000130102 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000130102 700__ $$aPlaza, Guillermo
000130102 700__ $$aIgnacio-Garcia, Jose Maria
000130102 700__ $$aBaptista Jardin, Peter
000130102 700__ $$aGarcia-Iriarte, Maria Teresa
000130102 700__ $$aCasado-Morente, Juan Carlos
000130102 700__ $$0(orcid)0000-0001-6724-5158$$aDe Vicente Gonzalez, Eugenio$$uUniversidad de Zaragoza
000130102 700__ $$aRodriguez-Reina, Agustin
000130102 7102_ $$11013$$2653$$aUniversidad de Zaragoza$$bDpto. Cirugía$$cÁrea Otorrinolaringología
000130102 773__ $$g4, 1 (2020), 1-10$$pSleep sci. pract.$$tSleep science and practice$$x2398-2683
000130102 8564_ $$s1348202$$uhttps://zaguan.unizar.es/record/130102/files/texto_completo.pdf$$yVersión publicada
000130102 8564_ $$s2370394$$uhttps://zaguan.unizar.es/record/130102/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000130102 909CO $$ooai:zaguan.unizar.es:130102$$particulos$$pdriver
000130102 951__ $$a2024-01-22-15:27:13
000130102 980__ $$aARTICLE